MAMS_6 - A Novel Transcriptome-Informed Quantitative Real-Time PCR-Based Signature for Monitoring Tuberculosis Treatment Success
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
Article activity feed
-
Strength of evidence
Reviewer(s): S Singh (All India Institute of Medical Sciences) | 📘📘📘📘📘
Z Gong (Karolinska Institute) | 📘📘📘📘📘 -
Zhen Gong
Review 2: "MAMS_6 - A Novel Transcriptome-Informed Quantitative Real-Time PCR-Based Signature for Monitoring Tuberculosis Treatment Success"
Reviewers recommend further comparison to already accepted standards such as the GeneXpert array of tests, and on other underrepresented cohorts such as people with HIV and patients with extrapulmonary Tuberculosis.
-
Sarman Singh
Review 1: "MAMS_6 - A Novel Transcriptome-Informed Quantitative Real-Time PCR-Based Signature for Monitoring Tuberculosis Treatment Success"
Reviewers recommend further comparison to already accepted standards such as the GeneXpert array of tests, and on other underrepresented cohorts such as people with HIV and patients with extrapulmonary Tuberculosis.
-